Kiromic, LLC   Report issue

For profit Phase 2
Founded: Houston TX United States (2012)
Status: Acquired by Generex Biotechnology Corp. (2019)

Organization Overview

First Clinical Trial
2016
NCT02705703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4